Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35001ca8bd47d22a9c1a0b5e15fe58fa |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-26 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-26 |
filingDate |
2001-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53d4b6ac4a7bce14dc6c1d14637d1971 |
publicationDate |
2001-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1142878-A2 |
titleOfInvention |
Pharmaceutical compositions comprising moexipril magnesium |
abstract |
Stable solid compositions comprising moxeipril magnesium can be madenusing moexipril or an acid addition salt thereof, by reacting the moxeipril ornacid addition salt with an alkaline magnesium compound in the presence of ansolvent, so as to convert most or all of the moexipril or acid addition salt tonmoexipril magnesium. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101812018-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101812018-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03063867-A1 |
priorityDate |
2000-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |